Muir W W, McGuirk S
Vet Clin North Am Equine Pract. 1987 Apr;3(1):37-57. doi: 10.1016/s0749-0739(17)30690-9.
Knowledge of the dosage, rate and route of administration, and potential side effects of drugs used to treat cardiac disease in horses has been refined. The judicious use of these drugs can increase exercise capacity, improve health, and potentially prolong life. Currently, antiarrhythmics (quinidine, lidocaine), positive inotropies (digoxin), and diuretics (furosemide) are the primary agents used to treat cardiovascular disease in horses. The development of newer drugs (verapamil, milrinone, bumetanide) and their usefulness in therapy for horses with cardiovascular disease require further investigation.
马类心脏病治疗药物的剂量、给药速率和途径以及潜在副作用的相关知识已得到完善。合理使用这些药物可提高运动能力、改善健康状况，并有可能延长寿命。目前，抗心律失常药（奎尼丁、利多卡因）、正性肌力药（地高辛）和利尿剂（呋塞米）是治疗马类心血管疾病的主要药物。新型药物（维拉帕米、米力农、布美他尼）的研发及其在马类心血管疾病治疗中的效用需要进一步研究。
